A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

Clinical trial NCT00213135 · COMPLETED

Trial details

NCT number: NCT00213135
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2005-04-01
Primary completion: 2008-11-01
Enrollment: 1326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.